The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 26, 2021

Filed:

Oct. 25, 2019
Applicant:

King Abdulaziz University, Jeddah, SA;

Inventors:

Moustafa E. El-Araby, Jeddah, SA;

Abdelsattar M. Omar, Jeddah, SA;

Martin K. Safo, Jeddah, SA;

Radwan S. Elhaggar, Jeddah, SA;

Tamer M. Abdelghany, Jeddah, SA;

Mostafa H. Ahmed, Jeddah, SA;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 295/108 (2006.01); C07D 307/52 (2006.01); C07D 209/14 (2006.01); C07D 213/75 (2006.01); C07D 295/15 (2006.01); C07D 207/06 (2006.01); C07D 233/40 (2006.01); C07D 333/24 (2006.01); C07D 241/04 (2006.01); C07D 295/13 (2006.01); C07C 233/40 (2006.01);
U.S. Cl.
CPC ...
C07D 295/108 (2013.01); C07C 233/40 (2013.01); C07D 207/06 (2013.01); C07D 209/14 (2013.01); C07D 213/75 (2013.01); C07D 241/04 (2013.01); C07D 295/13 (2013.01); C07D 307/52 (2013.01); C07D 333/24 (2013.01);
Abstract

A compound of formula (I), wherein Ris an optionally substituted aryl or an optionally substituted heteroaryl, Ris an optionally substituted aryl or an optionally substituted heteroaryl, and Ris an optionally substituted alkylamino, an optionally substituted cycloalkylamino, an optionally substituted arylamino, an optionally substituted heterocyclylamino, an optionally substituted heterocyclyl, and an optionally substituted dialkylamino. A pharmaceutical composition which includes the compound of formula (I) and a pharmaceutically acceptable carrier and/or excipient. A method of treating colorectal cancer in a subject, whereby a therapeutically effective amount of the compound of formula (I) is administered to the subject.


Find Patent Forward Citations

Loading…